雜志介紹

Translational Oncology雜志介紹

《Translational Oncology》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱轉(zhuǎn)化腫瘤學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.5，最新CiteScore 指數(shù)為8.4。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

  Author: Xu, Yingqi; Xu, Jianlin; Qiao, Rong; Zhong, Hua; Xia, Jinjing; Zhong, Runbo

• The roles of Linc-ROR in the regulation of cancer stem cells

  Author: Wen, Xiaoling; Wu, Yingying; Lou, Yanhui; Xia, Yufang; Yu, Xiao

• Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation

  Author: Jin, Xin; Ma, Xiaoting; Zhao, Dong; Yang, Lin; Ma, Nan

• circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p

  Author: Chen, Hongyu; Zhang, Jianwei; Yang, Lei; Li, Yansen; Wang, Zhenjun; Ye, Chunxiang

英文介紹

Translational Oncology雜志英文介紹

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.